a

a

Broadfin is a U. S. based healthcare long-short hedge fund investing in the following sectors: Medical technology and supplies, biotechnology, pharmaceuticals and medical services. The team has over 20 years investing experience in the industry. Its strategy is to target superior absolute returns through intense research and a non-consensus, value based investing approach.

Broadfin is a U. S. based healthcare long-short hedge fund investing in the following sectors: Medical technology and supplies, biotechnology, pharmaceuticals and medical services. The team has over 20 years investing experience in the industry. Its strategy is to target superior absolute returns through intense research and a non-consensus, value based investing approach.

www.hmstn.com

Healthcare Management Systems, Inc. was founded in 1984, the company develops, sells and supports integrated clinical and financial hospital information systems and services for the healthcare industry. Some of its products and services include: Financial and administrative software, Clinical software, Support and professional services and Software / Hardware implementation.

www.hmstn.com

Healthcare Management Systems, Inc. was founded in 1984, the company develops, sells and supports integrated clinical and financial hospital information systems and services for the healthcare industry. Some of its products and services include: Financial and administrative software, Clinical software, Support and professional services and Software / Hardware implementation.

www.prostrakan.com

ProStrakan is a rapidly growing specialty pharmaceutical company engaged in the in-licensing, development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major markets. The company’s current strategic focus is on the treatment of conditions related to women's health, the ageing male, and bone disease. ProStrakan is headquartered in Scotland and has commercial operations throughout the rest of the UK and continental Europe, employing approximately 200 people.

www.prostrakan.com

ProStrakan is a rapidly growing specialty pharmaceutical company engaged in the in-licensing, development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major markets. The company’s current strategic focus is on the treatment of conditions related to women's health, the ageing male, and bone disease. ProStrakan is headquartered in Scotland and has commercial operations throughout the rest of the UK and continental Europe, employing approximately 200 people.